Estimating national, regional and provincial cost-effectiveness of introducing childhood 13-valent pneumococcal conjugate vaccination in China: a modelling analysisResearch in context

Estimating national, regional and provincial cost-effectiveness of introducing childhood 13-valent pneumococcal conjugate vaccination in China: a modelling analysisResearch in context

Summary: Background: Although 13-valent pneumococcal conjugate vaccine (PCV13) is available in China's private market, it has yet to be introduced into the National Immunization Programme (NIP) and is therefore not available to large parts of the population. This study aimed to estimate the co...

Full description

Bibliographic Details
Main Authors: Xiaozhen Lai, Cristina Garcia, Dan Wu, Maria Deloria Knoll, Haijun Zhang, Tingting Xu, Rize Jing, Zundong Yin, Brian Wahl, Hai Fang
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:The Lancet Regional Health. Western Pacific
Subjects:
Streptococcus pneumoniae
Pneumococcal conjugate vaccination
China
Child health
Health economics
Economic analysis
Online Access:http://www.sciencedirect.com/science/article/pii/S2666606522002814

Internet

http://www.sciencedirect.com/science/article/pii/S2666606522002814

Similar Items